"Kettering Cancer Center, located in the Pavilion on Kettering Medical Center's campus is a full-service facilities intended to provide the most advanced patient-centered care in an environment that focuses on healing the whole person—body, mind, and spirit. The Kettering Cancer Care oncology experts and professionals of the Kettering Health will provide you with the most comprehensive, dedicated care in the Miami Valley. With diverse cancer care resources conveniently available throughout the region, no other healthcare provider in the Dayton area offers more far-reaching care."

During the past decade, Kettering Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kettering Cancer Center" #1 sponsor was "Aravive, Inc." with 1 trials, followed by "BioMed Valley Discoveries, Inc" with 1 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Mersana Therapeutics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kettering Cancer Center" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "GOG Foundation" with 2 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator, "GE Healthcare" with 1 trials as a collaborator and "Intuitive Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Kettering Cancer Center" are "Advanced Cancer" (1 trials), "Advanced Solid Tumor" (1 trials), "BRAF Gene Alteration" (1 trials), "BRAF Gene Mutation" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Kettering Cancer Center" in a lesser frequency.

Most popular intervention types in "Kettering Cancer Center" are "Drug" (6 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "18F Fluoroestradiol Radiopharmaceutical with PET/CT" (1 trials), "Afatinib" (1 trials), "Batiraxcept" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kettering Cancer Center" are 4 trials for "Female" genders, 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kettering Cancer Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kettering Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kettering Cancer Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".